Cargando…
Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells()
Diffuse intrinsic pontine glioma (DIPG) is a devastating disease with an extremely poor prognosis. Recent studies have shown that platelet-derived growth factor receptor (PDGFR) and its downstream effector pathway, PI3K/AKT/mTOR, are frequently amplified in DIPG, and potential therapies targeting th...
Autores principales: | Wu, Y. Linda, Maachani, Uday Bhanu, Schweitzer, Melanie, Singh, Ranjodh, Wang, Melinda, Chang, Raymond, Souweidane, Mark M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302185/ https://www.ncbi.nlm.nih.gov/pubmed/28189993 http://dx.doi.org/10.1016/j.tranon.2016.12.008 |
Ejemplares similares
-
Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment
por: Zhou, Zhiping, et al.
Publicado: (2017) -
Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy
por: Chang, Raymond, et al.
Publicado: (2019) -
Convection Enhanced Delivery for Diffuse Intrinsic Pontine Glioma: Review of a Single Institution Experience
por: Tosi, Umberto, et al.
Publicado: (2020) -
Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells
por: Du, Wei, et al.
Publicado: (2021) -
DIPG-49. BRAINSTEM AND PONTINE VOLUMETRIC ANALYSIS AS A SURROGATE MEASURE OF LOCAL DISEASE CONTROL IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Bander, Evan D, et al.
Publicado: (2020)